$7.48
0.233.19%
At Close: -
$7.79
0.314.12%
After Hours: Jul 15, 6:05 PM EDT
15 minutes delayed
Comments
Loading...
Pieris Pharmaceuticals
PIRSNASDAQ
Pieris Pharmaceuticals (NASDAQ:PIRS) Stock, Earnings Estimates, EPS, And Revenue
Pieris Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS
$-3.950
Quarterly Revenue
$53K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$40.9M
Analyze the earnings history of Pieris Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals | $0.05 | — | — | — | $20.05M | — | — | — | 08/08/2024 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$14.15 | — | -$3.95 | — | $1.94M | — | $53.00K | — | 05/15/2024 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.11 | -$0.12 | -$0.04 | 66.67% | $5.85M | $1.30M | $1.30M | -0.08% | 04/18/2024 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.13 | -$0.11 | -$0.11 | 0.00% | $5.37M | $7.74M | $19.52M | 152.20% | 11/14/2023 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.14 | -$0.16 | $0.05 | 131.25% | $3.70M | $4.02M | $20.05M | 398.88% | 08/10/2023 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.07 | -$0.14 | -$0.18 | -28.57% | $10.99M | $6.50M | $1.94M | -70.22% | 05/10/2023 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.13 | -$0.23 | -$0.11 | 52.17% | $8.44M | $6.51M | $5.85M | -10.20% | 03/29/2023 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.24 | -$0.16 | -$0.13 | 18.75% | $4.06M | $2.26M | $5.37M | 137.61% | 11/02/2022 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.25 | -$0.11 | -$0.14 | -27.27% | $3.29M | $10.47M | $3.70M | -64.68% | 08/04/2022 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.07 | -$0.11 | -$0.07 | 36.36% | $15.63M | $11.30M | $10.99M | -2.76% | 05/11/2022 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.26 | -$0.30 | -$0.13 | 56.67% | $1.88M | $2.45M | $8.44M | 244.61% | 03/01/2022 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.26 | -$0.24 | -$0.24 | 0.00% | $2.94M | $5.32M | $4.06M | -23.74% | 11/02/2021 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.09 | -$0.26 | -$0.25 | 3.85% | $11.25M | $2.07M | $3.29M | 58.70% | 08/04/2021 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.07 | -$0.17 | -$0.07 | 58.82% | $13.26M | $6.47M | $15.63M | 141.62% | 05/17/2021 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.06 | -$0.24 | -$0.26 | -8.33% | $17.27M | $3.82M | $1.88M | -50.86% | 03/30/2021 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.05 | -$0.13 | -$0.26 | -100.00% | $15.13M | $9.79M | $2.94M | -69.98% | 11/04/2020 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.24 | -$0.17 | -$0.09 | 47.06% | $5.33M | $7.76M | $11.25M | 44.92% | 08/10/2020 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.20 | -$0.17 | -$0.07 | 58.82% | $8.54M | $8.84M | $13.26M | 50.01% | 05/11/2020 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.21 | -$0.28 | -$0.06 | 78.57% | $4.91M | $4.82M | $17.27M | 258.30% | 03/12/2020 | Get Alert |
| PIRS | Pieris Pharmaceuticals | -$0.11 | -$0.23 | -$0.05 | 78.26% | $8.35M | $6.42M | $15.13M | 135.70% | 11/11/2019 | Get Alert |
| PIRS | Pieris Pharmaceuticals | $0.00 | -$0.20 | -$0.24 | -20.00% | $11.69M | $8.20M | $5.33M | -34.98% | 08/01/2019 | Get Alert |
Pieris Pharmaceuticals (PIRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-18 | $-0.04 | $-0.12 | 66.7 % |
| Sep 2023 | 2023-11-14 | $-0.11 | $-0.11 | 0.00 % |
| Jun 2023 | 2023-08-10 | $0.05 | $-0.16 | 131.3 % |
| Mar 2023 | 2023-05-10 | $-0.18 | $-0.14 | -28.6 % |
Pieris Pharmaceuticals (PIRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-18 | $1.30M | $1.30M | -0.08 % |
| Sep 2023 | 2023-11-14 | $19.52M | $7.74M | 152.2 % |
| Jun 2023 | 2023-08-10 | $20.06M | $4.02M | 398.9 % |
| Mar 2023 | 2023-05-10 | $1.94M | $6.50M | -70.2 % |
FAQ
When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?
Pieris Pharmaceuticals (PIRS) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Pieris Pharmaceuticals (NASDAQ:PIRS)?
The Actual EPS was $-3.95, which missed the estimate of $0.00.
What were Pieris Pharmaceuticals’s (NASDAQ:PIRS) revenues?
The Actual Revenue was $53K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.